Sorry, I think that's wishful thinking. I would just be thrilled to hear the CHF meeting actually getting scheduled. Given how they responded to our GVHD resubmission, I have little hope for a near term AA for CHF. What I expect is a trial with 1 year end point on ejection fraction, the results could then lead to AA or possibly full approval. We need a partner to fund; perhaps with some clear guidance from FDA we will get one. We are approaching 2 years since FDA requested that additional data from the CHF trial. Too many people dying from CHF - it is a travesty that this has been sitting on hold for so long.
Ann: Update on BLA for Graft Versus Host Disease, page-968
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |